Glycoconjugate-caged drugs offer better way to treat inflammatory bowel disease | Research

A novel targeted drug delivery system could help improve the efficacy of medicines for inflammatory bowel disease (IBD) by ensuring they are released directly to the affected area of the gut.

Medicines such as corticosteroids are generally…

Continue Reading